Pfizer axes new weight loss pill after patients experience serious side effects
Pfizer is discontinuing danuglipron, its twice-daily weight loss pill, after more than half of patients in a clinical trial stopped taking it.
Archives for December 4, 2023
GSK RSV vaccine revenue to reach $1.26 billion in first year, CEO says
GSK CEO Emma Walmsley has told Reuters that the company’s respiratory syncytial virus (RSV) vaccine is expected to make over $1.26 billion in its first year on the market.
Mytos announces $19 million series A funding to automate human cell manufacturing
Mytos, a London-based automated cell manufacturing company, has closed $19 million in Series A financing led by Buckley Ventures, with participation from IQ Capital and Wing VC.